Liposomal coencapsulated fludarabine and
โ
Xiaobin Zhao; Jianmei Wu; Natarajan Muthusamy; John C. Byrd; Robert J. Lee
๐
Article
๐
2008
๐
John Wiley and Sons
๐
English
โ 295 KB
Fludarabine (FLU)-based combination therapies are commonly used to treat low-grade lymphoma and chronic lymphocytic leukemia (CLL) patients. In vitro and clinical studies have indicated advantages when FLU and mitoxantrone (MTO) are applied in combination. To further enhance this effect, these two a